DaVita HealthCare Partners Inc (DVA) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.306x

Based on the latest financial reports, DaVita HealthCare Partners Inc (DVA) has a cash flow conversion efficiency ratio of 0.306x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($320.83 Million) by net assets ($1.05 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See DVA equity to assets ratio to measure how much of total assets are equity-financed.

DaVita HealthCare Partners Inc - Cash Flow Conversion Efficiency Trend (1994–2025)

This chart illustrates how DaVita HealthCare Partners Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check DaVita HealthCare Partners Inc (DVA) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

DaVita HealthCare Partners Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of DaVita HealthCare Partners Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Aier Eye Hospital Group
SHE:300015
0.069x
AB SKF (publ)
ST:SKF-B
-0.008x
ageas SA/NV
BR:AGS
0.069x
Realtek Semiconductor Corp
TW:2379
0.109x
DWS Group GmbH & Co. KGaA
XETRA:DWS
0.033x
Phison Electronics
TWO:8299
0.036x
Carrefour SA
PA:CA
0.366x
Align Technology Inc
NASDAQ:ALGN
0.036x

Annual Cash Flow Conversion Efficiency for DaVita HealthCare Partners Inc (1994–2025)

The table below shows the annual cash flow conversion efficiency of DaVita HealthCare Partners Inc from 1994 to 2025. For the full company profile with market capitalisation and key ratios, see DVA company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $1.16 Billion $1.89 Billion 1.628x +68.43%
2024-12-31 $2.09 Billion $2.02 Billion 0.967x +28.82%
2023-12-31 $2.74 Billion $2.06 Billion 0.751x +6.73%
2022-12-31 $2.22 Billion $1.56 Billion 0.703x -13.65%
2021-12-31 $2.37 Billion $1.93 Billion 0.814x +19.20%
2020-12-31 $2.90 Billion $1.98 Billion 0.683x +15.37%
2019-12-31 $3.50 Billion $2.07 Billion 0.592x +68.23%
2018-12-31 $5.03 Billion $1.77 Billion 0.352x +8.83%
2017-12-31 $5.90 Billion $1.91 Billion 0.323x -4.08%
2016-12-31 $5.82 Billion $1.96 Billion 0.337x +28.80%
2015-12-31 $5.95 Billion $1.56 Billion 0.262x +11.04%
2014-12-31 $6.19 Billion $1.46 Billion 0.236x -29.50%
2013-12-31 $5.30 Billion $1.77 Billion 0.334x +36.97%
2012-12-31 $4.51 Billion $1.10 Billion 0.244x -53.07%
2011-12-31 $2.27 Billion $1.18 Billion 0.520x +26.22%
2010-12-31 $2.04 Billion $839.68 Million 0.412x +35.65%
2009-12-31 $2.19 Billion $666.71 Million 0.304x +15.78%
2008-12-31 $2.12 Billion $555.93 Million 0.262x -7.30%
2007-12-31 $1.88 Billion $533.04 Million 0.283x -25.44%
2006-12-31 $1.37 Billion $519.57 Million 0.380x -26.55%
2005-12-31 $939.25 Million $485.55 Million 0.517x -29.05%
2004-12-31 $576.33 Million $419.94 Million 0.729x -15.59%
2003-12-31 $340.16 Million $293.65 Million 0.863x -75.64%
2002-12-31 $96.49 Million $342.00 Million 3.544x +581.42%
2001-12-31 $524.36 Million $272.73 Million 0.520x -37.74%
2000-12-31 $368.24 Million $307.65 Million 0.835x +72.58%
1999-12-31 $348.98 Million $168.94 Million 0.484x +1289.60%
1998-12-31 $505.20 Million $17.60 Million 0.035x +75.87%
1997-12-31 $292.80 Million $5.80 Million 0.020x -74.63%
1996-12-31 $235.70 Million $18.40 Million 0.078x +6.69%
1995-12-31 $86.10 Million $6.30 Million 0.073x +112.41%
1994-12-31 $-25.60 Million $15.10 Million -0.590x --

About DaVita HealthCare Partners Inc

NYSE:DVA USA Medical Care Facilities
Market Cap
$12.11 Billion
Market Cap Rank
#1938 Global
#728 in USA
Share Price
$188.69
Change (1 day)
-17.24%
52-Week Range
$103.87 - $240.96
All Time High
$240.96
About

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for di… Read more